# Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C

> **NCT06564051** · — · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 29 (actual)

## Conditions studied

- Chronic Viral Hepatitis C
- Monoclonal B-Cell Lymphocytosis

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT06564051
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-14
- **Primary completion:** 2025-12-03
- **Final completion:** 2025-12-03
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06564051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06564051, "Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06564051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*